Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (941)	2/7/2002 11:48:25 AM
From: aknahow	Read Replies (1) \| Respond to of 2243

BGEN/ELN Antegren agreement is 50% sharing according to recent presentation comments by BGEN C.E.O. Antegren is very interesting. It is impossible to believe that BGEN is not looking at all its' options to acquire ELN or at least the Antegren program. The threat of an unknown competitor becoming a joint partner for Antegren is too great. BGEN could sell off any areas it felt did not make a good fit. The bid for ELN if one ever comes from anyone IMO won't be much above 50% over the average price of ELN in the week prior to the bid.